Yes, a patient on a statin can safely take ibuprofen (Motrin) on an as-needed basis.
There is no clinically significant drug-drug interaction between statins and ibuprofen, and PRN use of ibuprofen does not increase the risk of statin-associated myopathy or other adverse effects.
Key Evidence
The available guideline evidence from ACC/AHA/NHLBI extensively details drugs that interact with statins and increase myopathy risk. Notably, NSAIDs like ibuprofen are not listed among the medications that cause statin drug interactions 1. The relative contraindications for statin use specifically include cyclosporine, gemfibrozil, niacin, macrolide antibiotics, antifungal agents, and cytochrome P-450 inhibitors—but not NSAIDs 1.
Clinical Reasoning
Why This Combination Is Safe
Different metabolic pathways: Statins are primarily metabolized through CYP3A4 (for most statins) or CYP2C9 (for rosuvastatin), while ibuprofen does not significantly inhibit these pathways 2, 3
No documented interaction: Multiple comprehensive reviews of statin drug-drug interactions do not identify NSAIDs as problematic agents 2, 3, 4
PRN use further reduces risk: As-needed dosing of ibuprofen minimizes any theoretical concerns about chronic co-administration
Important Caveats for NSAID Use
While the statin-ibuprofen combination is safe, patients on statins who take ibuprofen should still be counseled about standard NSAID risks 5:
- Gastrointestinal bleeding risk increases in patients ≥60 years, those with prior ulcers, or those taking anticoagulants
- Cardiovascular risks including increased risk of heart attack and stroke with prolonged NSAID use
- Renal toxicity particularly in patients with compromised renal function or diabetes—populations already at higher risk for statin myopathy 1
Monitoring Remains Standard
Continue routine statin monitoring regardless of ibuprofen use 1:
- Evaluate muscle symptoms at baseline, 6-12 weeks after starting therapy, and at each follow-up
- Check CK only if muscle symptoms develop
- Monitor liver enzymes at baseline, 12 weeks, then annually
High-Risk Populations Requiring Extra Caution
Be more vigilant in patients with multiple risk factors for statin myopathy 1:
- Advanced age (especially >80 years)
- Small body frame and frailty
- Multisystem disease (chronic renal insufficiency, especially with diabetes)
- Multiple medications (polypharmacy)
In these high-risk patients, the concern is not the statin-ibuprofen interaction itself, but rather the cumulative burden of multiple medications and the independent NSAID risks in vulnerable populations.